BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Fang J, Chen S, Liu H, Zhou J, Huang J, Liu S, Peng Y. A Risk Model Developed Based on Necroptosis Predicts Overall Survival for Hepatocellular Carcinoma and Identification of Possible Therapeutic Drugs. Front Immunol 2022;13:870264. [PMID: 35422802 DOI: 10.3389/fimmu.2022.870264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Hua L, Lei P, Hu Y. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients. Sci Rep 2022;12:15893. [PMID: 36151259 DOI: 10.1038/s41598-022-20217-4] [Reference Citation Analysis]
2 Liu Y, Zhou X, Wang F, Liu C, Xie J, Guan L, Xie Y. Bibliometric analysis of publications on necroptosis from 2001 to 2021. Front Cell Dev Biol 2022;10:946363. [DOI: 10.3389/fcell.2022.946363] [Reference Citation Analysis]
3 Fu X, Yang Y, Zhang X. A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma. Front Genet 2022;13:919599. [DOI: 10.3389/fgene.2022.919599] [Reference Citation Analysis]